BioNeutral Group, Inc Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
BioNeutral Group, Inc reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $1.39 million for the 9-month period ending 2014-07-31, per its 10-Q filed 2014-09-22.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2014-09-22
- BioNeutral Group, Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2014-07-31 was $390.55K, a 511.22% increase year-over-year.
- BioNeutral Group, Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2014-04-30 was $968.09K, a 3045.60% increase year-over-year.
- BioNeutral Group, Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2014-01-31 was $36.00K, a 80.36% decline year-over-year.
- BioNeutral Group, Inc fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2013-10-31 was $230.65K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month as first filed |
|---|---|---|---|---|---|
| 2014-07-31 | $390.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-22 | $1.36M derived: sum of 2 quarters · filed 2014-09-22 | $1.39M 10-Q · filed 2014-09-22 | $1.63M derived: sum of 4 quarters · filed 2014-09-22 | |
| 2014-04-30 | $968.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-20 | $1.00M 10-Q · filed 2014-06-20 | $1.23M derived: sum of 3 quarters · filed 2014-09-22 | $1.30M derived: sum of 4 quarters · filed 2014-09-22 | |
| 2014-01-31 | $36.00K 10-Q · filed 2014-03-14 | $266.65K derived: sum of 2 quarters · filed 2014-09-22 | $330.55K derived: sum of 3 quarters · filed 2014-09-22 | $361.32K derived: sum of 4 quarters · filed 2014-09-22 | |
| 2013-10-31 | $230.65K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-09-22 | $294.55K derived: sum of 2 quarters · filed 2014-09-22 | $325.32K derived: sum of 3 quarters · filed 2014-09-22 | $508.61K 10-Q · filed 2014-09-22 | $337.22K 10-K · filed 2014-02-13 |
| 2013-07-31 | $63.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-16 | $94.67K derived: sum of 2 quarters · filed 2013-09-16 | $277.96K 10-Q · filed 2013-09-16 | ||
| 2013-04-30 | $30.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-24 | $214.06K 10-Q · filed 2013-06-24 | |||
| 2013-01-31 | $183.28K 10-Q · filed 2013-03-15 |